APA (7th ed.) Citation

Cox, K., Dineen, N., Weeks, J., Allen, D., Akolekar, D., Chalmers, R., . . . Abson, C. (2020). 354 Poster - Enhanced axillary assessment using contrast enhanced ultrasound (CEUS) before neo-adjuvant systemic therapy (NACT) in breast cancer patients identifies axillary disease missed by conventional B-mode ultrasound that may be clinically relevant. European Journal of Cancer, 138, S89. https://doi.org/10.1016/S0959-8049(20)30773-5

Chicago Style (17th ed.) Citation

Cox, K., et al. "354 Poster - Enhanced Axillary Assessment Using Contrast Enhanced Ultrasound (CEUS) Before Neo-adjuvant Systemic Therapy (NACT) in Breast Cancer Patients Identifies Axillary Disease Missed by Conventional B-mode Ultrasound That May Be Clinically Relevant." European Journal of Cancer 138 (2020): S89. https://doi.org/10.1016/S0959-8049(20)30773-5.

MLA (9th ed.) Citation

Cox, K., et al. "354 Poster - Enhanced Axillary Assessment Using Contrast Enhanced Ultrasound (CEUS) Before Neo-adjuvant Systemic Therapy (NACT) in Breast Cancer Patients Identifies Axillary Disease Missed by Conventional B-mode Ultrasound That May Be Clinically Relevant." European Journal of Cancer, vol. 138, 2020, p. S89, https://doi.org/10.1016/S0959-8049(20)30773-5.